Attorneys with Quinn Emanuel Urquhart & Sullivan recently filed a breach-of-contract suit in a Massachusetts state court on behalf of a biotech manufacturer seeking $100 million in damages for its efforts in securing regulatory rights for another company’s branded over-the-counter COVID-19 test.
The Aug. 14 complaint, filed in Middlesex County Superior Court on behalf of a San Diego-based biotechnology company, CorDx, and its subsidiaries, Bao Ruiyan Biotech (Beijin) Co., and Core Technology Co., accused the Massachusetts-based seller of self-testing products, Genabio Diagnostics, and its executive leader, Weike Mo, of failing to follow through with an agreement. Through a partnership, the Genabio defendants gave CorDX exclusive manufacturer rights of Genabio’s branded COVID-19 testing kits. In exchange, CorDX was to receive half of all the net profits from the test kits that were sold and have distribution rights for at least one-third of the tests, among other things.
